-
53 Publicações
-
0 fotos
-
0 Vídeos
-
Female
-
19/01/2000
-
Seguido por 6 pessoas
© 2026 ULYSTAR <<<<Express Yourself>>>>
Portuguese (Brazil)
Atualizações recentes
-
High-Purity Cynomolgus Monkey Umbilical Vein Endothelial Cells for ResearchEndothelial cells play a central role in maintaining vascular homeostasis, regulating permeability, and mediating inflammatory responses. Among the various endothelial cell models available, Cynomolgus Monkey HUVEC cells stand out as a valuable system for researchers seeking a closer approximation to human endothelial function. Derived from the umbilical vein of Macaca fascicularis...0 Comentários 0 Compartilhamentos 220 Visualizações 0 AnteriorFaça o login para curtir, compartilhar e comentar!
-
The Self-Copying Cure: Why "saRNA" is the Next Giant Leap Beyond Traditional mRNAIn the early 2020s, mRNA became a household name. It was the biological "software" that taught our cells to fight back. But as we move through 2026, the scientific community is asking a critical question: Can we make this software run longer, faster, and on a much smaller battery? The answer lies in a radical evolution of the technology—shifting from simple messenger RNA to...0 Comentários 0 Compartilhamentos 246 Visualizações 0 Anterior
-
Two Hands for a Thousand Shadows: How Bispecifics Are Ending the Game of Molecular Hide-and-SeekFor decades, the Y-shaped IgG molecule has been the undisputed heavyweight champion of precision medicine. It’s elegant, stable, and remarkably effective. But as we dive deeper into the chaotic microenvironments of refractory cancers and complex autoimmune "cross-talk," a sobering realization has set in: sometimes, two hands aren’t enough. In the high-stakes world of...0 Comentários 0 Compartilhamentos 286 Visualizações 0 Anterior
-
The Three Building Blocks That Power Modern Degrader InnovationThe rise of targeted protein degradation (TPD) has opened a new chapter in modern drug discovery. Unlike traditional inhibitors that merely block protein activity, degraders work by eliminating disease-causing proteins altogether through the ubiquitin–proteasome system. Behind this elegant mechanism lies a delicate balance between three essential components — linkers, ligands, and...0 Comentários 0 Compartilhamentos 241 Visualizações 0 Anterior
-
A Dance of Restraint: When the Biological "Power Button" Gets StuckIn the microscopic, bustling metropolis of a human cell, there is a boardroom that never sleeps. Thousands of messages arrive every second, demanding immediate action: “Break down fat now!” or “Speed up the heartbeat!” or “Divide the DNA!” To handle this chaos, the cell doesn't just react blindly. It uses a sophisticated "management and execution" system...0 Comentários 0 Compartilhamentos 254 Visualizações 0 Anterior
-
Why Ex Vivo Gastrointestinal Models Are Redefining Human-Relevant ResearchA new kind of gold rush is quietly reshaping drug discovery—and this time, the treasure is not buried in animal facilities or clinical trial databases, but preserved in living human gastrointestinal tissue. As pharmaceutical pipelines accelerate and regulatory expectations tighten, traditional in vivo models are showing their limits. Animal studies remain costly,...0 Comentários 0 Compartilhamentos 447 Visualizações 0 Anterior
-
Unlocking the Potential of Rheumatoid Arthritis and Asthma Models in Modern PharmacologyThe pharmaceutical landscape is entering a phase of unprecedented focus on immune-mediated diseases, with research teams racing to develop treatments for conditions ranging from autoimmune disorders to chronic inflammatory diseases. The key to this progress is not just advanced molecular tools—it is also the strategic use of robust preclinical disease models that faithfully recapitulate...0 Comentários 0 Compartilhamentos 519 Visualizações 0 Anterior
-
2025 ADC Landscape: What Emerging Payloads Reveal About the Future of Targeted TherapiesAntibody–drug conjugates (ADCs) continue to reshape the oncology pipeline, driven by the pursuit of payloads that can deliver stronger potency, improved tumor selectivity, and reduced systemic toxicity. Although more than a decade has passed since the approval of the first ADC, payload development remains one of the fastest-moving components of the field. With growing interest in high-DAR...0 Comentários 0 Compartilhamentos 490 Visualizações 0 Anterior
-
Why Researchers Are Turning to Non-IgG Immunoglobulins for High-Impact DiscoveriesFor years, the life sciences community has focused its attention—and budgets—on IgG antibodies. They were the gold standard for therapeutic development, biomarker screening, and diagnostic innovation. But as biological questions grow more complex and precision medicine becomes increasingly nuanced, a new trend has emerged: a surge of interest in non-IgG antibodies and proteins....0 Comentários 0 Compartilhamentos 453 Visualizações 0 Anterior
-
From Noise to Precision: The Rise of Single-Cell Technologies in Antibody and Immunology ResearchThe biotech world is experiencing a new kind of gold rush—not in primate facilities this time, but inside single cells. As immunotherapy, next-generation vaccines, and precision biologics reshape modern medicine, researchers are fighting to unlock the deepest layers of immune complexity. And the key to that treasure lies in high-resolution single-cell data. "Everything now depends...0 Comentários 0 Compartilhamentos 475 Visualizações 0 Anterior
Mais stories